Ignite Creation Date:
2025-12-24 @ 11:41 PM
Ignite Modification Date:
2026-01-02 @ 8:33 PM
Study NCT ID:
NCT03212651
Status:
COMPLETED
Last Update Posted:
2023-01-20
First Post:
2017-07-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study Evaluating Neoadjuvant Pembrolizumab Monotherapy in Patients With Muscle-Invasive Bladder Cancer to Explore in Vivo the Mechanisms of Action of Pembrolizumab
Sponsor:
Gustave Roussy, Cancer Campus, Grand Paris
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10-17
Start Date Type:
ACTUAL
Primary Completion Date:
2019-07-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-12-13
Completion Date Type:
ACTUAL
First Submit Date:
2017-07-06
First Submit QC Date:
None
Study First Post Date:
2017-07-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-19
Last Update Post Date:
2023-01-20
Last Update Post Date Type:
ACTUAL